← Back to Search

Preoperative Breast MRI for Breast Cancer

N/A
Waitlist Available
Led By Kimberly Van Zee, MD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age less than 60 at time of consent
Female
Must not have
Age 60 or over at time of consent
Patients with contraindications to breast conservation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

This trial is studying the use of breast MRI in addition to mammography in women who have already been diagnosed with breast cancer to see if it can help find other areas of cancer.

Who is the study for?
This trial is for women under 60 with a specific breast cancer diagnosis (DCIS or DCIS with microinvasion) who haven't had certain biopsies or surgeries yet. They must be able to have breast surgery at MSKCC and not be pregnant, nursing, or have conditions that make MRI unsafe like pacemakers, metal implants, severe weight over 350 lb., allergies to MRI contrast agents, or metal in the eye.
What is being tested?
The study tests how effective Breast MRI is in detecting additional cancer areas in women already diagnosed with one area of breast cancer. It examines if the MRI influences treatment decisions and compares image findings with microscopic tissue analysis. Participants will also be followed for ten years to monitor cancer recurrence.
What are the potential side effects?
MRI generally has few side effects but can include discomfort from lying still during the procedure, loud noises during scanning which may require ear protection, and rare allergic reactions to the contrast agent used.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am under 60 years old.
Select...
I am female.
Select...
My breast surgery will be done at MSKCC.
Select...
My breast cancer is in a very early stage, confirmed by a core biopsy.
Select...
My cancer was diagnosed at an early stage.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am 60 years old or older.
Select...
I cannot have breast-saving surgery due to my condition.
Select...
I had a surgical biopsy for DCIS or DCIS with slight invasion before joining.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
Women with core biopsy proven DCIS with or without microinvasion seen for surgical consultation at Memorial Sloan-Kettering Cancer Center and for whom operative intervention is planned.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MRI
2009
Completed Phase 2
~1620

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,956 Previous Clinical Trials
595,441 Total Patients Enrolled
Kimberly Van Zee, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
2 Previous Clinical Trials
1,460 Total Patients Enrolled

Media Library

MRI Clinical Trial Eligibility Overview. Trial Name: NCT00605982 — N/A
Ductal Carcinoma Research Study Groups: 1
Ductal Carcinoma Clinical Trial 2023: MRI Highlights & Side Effects. Trial Name: NCT00605982 — N/A
MRI 2023 Treatment Timeline for Medical Study. Trial Name: NCT00605982 — N/A
~0 spots leftby Oct 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top